“…Thus, bioactive fish PL, like phospholipids and glycolipids baring n-3 PUFA in their structure, possess much higher bioavailability of their n-3 PUFA when compared to neutral forms of TAG or lipid esters of the n-3 PUFA, due to their amphiphilic properties (they “travel” in plasma lipoproteins and are incorporated into cell-membranes more easily, including surpassing the blood-brain barrier) [ 6 , 29 , 32 , 68 ]. Consequently, fish PL rich in n-3 PUFA have been found to reduce the risk for inflammation-related chronic disorders, such as atherosclerosis and CVD, and improve neural function in much lower amounts, like those found in moderate consumption of fish (0.25 g/day), partly due to their higher bioavailability of their bio-functional n-3 PUFA content [ 6 , 9 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 60 , 63 ]. Fish PL have been suggested to act as more effective modes of transports for n-3 PUFA [ 33 , 68 ], and thus having higher anti-thrombotic and anti-inflammatory bio-efficacy [ 9 , 26 , 27 , 30 , 31 , 60 ].…”